...
首页> 外文期刊>Critical care : >Early propranolol treatment induces lung heme-oxygenase-1, attenuates metabolic dysfunction, and improves survival following experimental sepsis
【24h】

Early propranolol treatment induces lung heme-oxygenase-1, attenuates metabolic dysfunction, and improves survival following experimental sepsis

机译:早期普萘洛尔治疗可诱发肺血红素加氧酶-1,减轻代谢功能障碍,并改善实验性败血症后的存活率

获取原文
           

摘要

IntroductionPharmacological agents that block beta-adrenergic receptors have been associated with improved outcome in burn injury. It has been hypothesized that injuries leading to a hypermetabolic state, such as septic shock, may also benefit from beta-blockade; however, outcome data in experimental models have been contradictory. Thus, we investigated the effect of beta-blockade with propranolol on survival, hemodynamics, lung heat shock protein (HSP) expression, metabolism and inflammatory markers in a rat cecal ligation and puncture (CLP) model of sepsis.MethodsSprague-Dawley rats receiving either repeated doses (30 minutes pre-CLP and every 8 hours for 24 hours postoperatively) of propranolol or control (normal saline), underwent CLP and were monitored for survival. Additionally, lung and blood samples were collected at 6 and 24 hours for analysis. Animals also underwent monitoring to evaluate global hemodynamics.ResultsSeven days following CLP, propranolol improved survival versus control (P < 0.01). Heart rates in the propranolol-treated rats were approximately 23% lower than control rats (P < 0.05) over the first 24 hours, but the mean arterial blood pressure was not different between groups. Metabolic analysis of lung tissue demonstrated an increase in lung ATP/ADP ratio and NAD+ content and a decreased ratio of polyunsaturated fatty acids to monounsaturated fatty acids (PUFA/MUFA). Cytokine analysis of the inflammatory cytokine tumor necrosis factor alpha (TNF-alpha) demonstrated decreased expression of TNF-alpha in both lung and plasma at 24 hours post CLP induced sepsis. Finally, propranolol led to a significant increase in lung hemeoxygenase-1 expression, a key cellular protective heat shock protein (HSP) in the lung. Other lung HSP expression was unchanged.ConclusionsThese results suggest that propranolol treatment may decrease mortality during sepsis potentially via a combination of improving metabolism, suppressing aspects of the inflammatory response and enhancing tissue protection.
机译:引言阻断β-肾上腺素能受体的药物与烧伤的预后改善有关。据推测,导致代谢亢进状态的损伤(如败血性休克)也可能受益于β受体阻滞剂。然而,实验模型中的结果数据是矛盾的。因此,我们在败血症的大鼠盲肠结扎穿刺(CLP)模型中研究了普萘洛尔β受体阻滞剂对存活,血液动力学,肺热休克蛋白(HSP)表达,代谢和炎性标志物的影响。重复剂量(CLP前30分钟,术后8小时,术后24小时每8小时)对心得安或对照组(生理盐水)进行CLP,并监测其存活率。此外,在第6和24小时收集肺和血液样本进行分析。结果还进行了监测,以评估整体的血流动力学。结果CLP后7天,普萘洛尔相对于对照组改善了生存期(P <0.01)。在最初的24小时内,经心得安治疗的大鼠的心率比对照组低约23%(P <0.05),但是两组之间的平均动脉血压没有差异。肺组织的代谢分析表明,肺ATP / ADP比例和NAD +含量增加,多不饱和脂肪酸与单不饱和脂肪酸(PUFA / MUFA)的比例降低。炎症细胞因子肿瘤坏死因子α(TNF-alpha)的细胞因子分析表明,CLP诱发败血症后24小时,肺和血浆中TNF-α的表达降低。最后,普萘洛尔可导致肺血红素加氧酶-1(肺血中重要的细胞保护性热休克蛋白(HSP))表达显着增加。其他肺HSP表达未改变。结论这些结果表明,普萘洛尔治疗可通过改善代谢,抑制炎症反应和增强组织保护相结合来降低败血症死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号